nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Fungal skin infection—Thalidomide—leprosy	0.038	0.038	CcSEcCtD
Linezolid—Tongue discolouration—Thalidomide—leprosy	0.0329	0.0329	CcSEcCtD
Linezolid—Peripheral vascular disorder—Thalidomide—leprosy	0.0324	0.0324	CcSEcCtD
Linezolid—Transient ischaemic attack—Thalidomide—leprosy	0.0315	0.0315	CcSEcCtD
Linezolid—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.031	0.031	CcSEcCtD
Linezolid—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.0273	0.0273	CcSEcCtD
Linezolid—Platelet count decreased—Thalidomide—leprosy	0.0267	0.0267	CcSEcCtD
Linezolid—Oral candidiasis—Thalidomide—leprosy	0.025	0.025	CcSEcCtD
Linezolid—Skin ulcer—Thalidomide—leprosy	0.0204	0.0204	CcSEcCtD
Linezolid—Pancreatitis—Dapsone—leprosy	0.0191	0.0191	CcSEcCtD
Linezolid—Apnoea—Thalidomide—leprosy	0.0187	0.0187	CcSEcCtD
Linezolid—Jaundice cholestatic—Thalidomide—leprosy	0.0181	0.0181	CcSEcCtD
Linezolid—Drug interaction—Thalidomide—leprosy	0.0171	0.0171	CcSEcCtD
Linezolid—Neuropathy peripheral—Dapsone—leprosy	0.017	0.017	CcSEcCtD
Linezolid—Pharyngitis—Dapsone—leprosy	0.0155	0.0155	CcSEcCtD
Linezolid—Candida infection—Thalidomide—leprosy	0.0152	0.0152	CcSEcCtD
Linezolid—Neuropathy—Thalidomide—leprosy	0.0149	0.0149	CcSEcCtD
Linezolid—Tinnitus—Dapsone—leprosy	0.0145	0.0145	CcSEcCtD
Linezolid—Sepsis—Thalidomide—leprosy	0.0138	0.0138	CcSEcCtD
Linezolid—Erythema—Dapsone—leprosy	0.0136	0.0136	CcSEcCtD
Linezolid—Thrombophlebitis—Thalidomide—leprosy	0.0133	0.0133	CcSEcCtD
Linezolid—Vision blurred—Dapsone—leprosy	0.0128	0.0128	CcSEcCtD
Linezolid—Cardiac failure congestive—Thalidomide—leprosy	0.0127	0.0127	CcSEcCtD
Linezolid—Injury—Thalidomide—leprosy	0.0125	0.0125	CcSEcCtD
Linezolid—Vertigo—Dapsone—leprosy	0.0122	0.0122	CcSEcCtD
Linezolid—Cough—Dapsone—leprosy	0.0118	0.0118	CcSEcCtD
Linezolid—Hypoglycaemia—Thalidomide—leprosy	0.0118	0.0118	CcSEcCtD
Linezolid—Hyponatraemia—Thalidomide—leprosy	0.0116	0.0116	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.0115	0.0115	CcSEcCtD
Linezolid—Liver function test abnormal—Thalidomide—leprosy	0.0106	0.0106	CcSEcCtD
Linezolid—Hypokalaemia—Thalidomide—leprosy	0.0105	0.0105	CcSEcCtD
Linezolid—Cramp muscle—Thalidomide—leprosy	0.0104	0.0104	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Thalidomide—leprosy	0.0104	0.0104	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Linezolid—Insomnia—Dapsone—leprosy	0.01	0.01	CcSEcCtD
Linezolid—Eosinophilia—Thalidomide—leprosy	0.00987	0.00987	CcSEcCtD
Linezolid—Pancreatitis—Thalidomide—leprosy	0.00977	0.00977	CcSEcCtD
Linezolid—Pancytopenia—Thalidomide—leprosy	0.00947	0.00947	CcSEcCtD
Linezolid—Neutropenia—Thalidomide—leprosy	0.00932	0.00932	CcSEcCtD
Linezolid—Upper respiratory tract infection—Thalidomide—leprosy	0.00926	0.00926	CcSEcCtD
Linezolid—Gastrointestinal pain—Dapsone—leprosy	0.00905	0.00905	CcSEcCtD
Linezolid—Hyperglycaemia—Thalidomide—leprosy	0.00899	0.00899	CcSEcCtD
Linezolid—Pneumonia—Thalidomide—leprosy	0.00894	0.00894	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00881	0.00881	CcSEcCtD
Linezolid—Abdominal pain—Dapsone—leprosy	0.00875	0.00875	CcSEcCtD
Linezolid—Body temperature increased—Dapsone—leprosy	0.00875	0.00875	CcSEcCtD
Linezolid—Renal failure—Thalidomide—leprosy	0.00874	0.00874	CcSEcCtD
Linezolid—Neuropathy peripheral—Thalidomide—leprosy	0.00871	0.00871	CcSEcCtD
Linezolid—Stomatitis—Thalidomide—leprosy	0.00866	0.00866	CcSEcCtD
Linezolid—Hypoaesthesia—Thalidomide—leprosy	0.00794	0.00794	CcSEcCtD
Linezolid—Pharyngitis—Thalidomide—leprosy	0.00792	0.00792	CcSEcCtD
Linezolid—Erythema multiforme—Thalidomide—leprosy	0.00754	0.00754	CcSEcCtD
Linezolid—Tinnitus—Thalidomide—leprosy	0.00744	0.00744	CcSEcCtD
Linezolid—Chills—Thalidomide—leprosy	0.00716	0.00716	CcSEcCtD
Linezolid—Vomiting—Dapsone—leprosy	0.00704	0.00704	CcSEcCtD
Linezolid—Headache—Dapsone—leprosy	0.00694	0.00694	CcSEcCtD
Linezolid—Flatulence—Thalidomide—leprosy	0.00684	0.00684	CcSEcCtD
Linezolid—Dysgeusia—Thalidomide—leprosy	0.0068	0.0068	CcSEcCtD
Linezolid—Muscle spasms—Thalidomide—leprosy	0.00668	0.00668	CcSEcCtD
Linezolid—Nausea—Dapsone—leprosy	0.00658	0.00658	CcSEcCtD
Linezolid—Vision blurred—Thalidomide—leprosy	0.00655	0.00655	CcSEcCtD
Linezolid—Anaemia—Thalidomide—leprosy	0.00642	0.00642	CcSEcCtD
Linezolid—Angioedema—Thalidomide—leprosy	0.00635	0.00635	CcSEcCtD
Linezolid—Vertigo—Thalidomide—leprosy	0.00624	0.00624	CcSEcCtD
Linezolid—Leukopenia—Thalidomide—leprosy	0.00622	0.00622	CcSEcCtD
Linezolid—Cough—Thalidomide—leprosy	0.00606	0.00606	CcSEcCtD
Linezolid—Convulsion—Thalidomide—leprosy	0.00602	0.00602	CcSEcCtD
Linezolid—Hypertension—Thalidomide—leprosy	0.006	0.006	CcSEcCtD
Linezolid—Dry mouth—Thalidomide—leprosy	0.00578	0.00578	CcSEcCtD
Linezolid—Thrombocytopenia—Thalidomide—leprosy	0.00555	0.00555	CcSEcCtD
Linezolid—Skin disorder—Thalidomide—leprosy	0.00551	0.00551	CcSEcCtD
Linezolid—Hyperhidrosis—Thalidomide—leprosy	0.00548	0.00548	CcSEcCtD
Linezolid—Anorexia—Thalidomide—leprosy	0.0054	0.0054	CcSEcCtD
Linezolid—Insomnia—Thalidomide—leprosy	0.00513	0.00513	CcSEcCtD
Linezolid—Paraesthesia—Thalidomide—leprosy	0.00509	0.00509	CcSEcCtD
Linezolid—Dyspnoea—Thalidomide—leprosy	0.00505	0.00505	CcSEcCtD
Linezolid—Somnolence—Thalidomide—leprosy	0.00504	0.00504	CcSEcCtD
Linezolid—Dyspepsia—Thalidomide—leprosy	0.00499	0.00499	CcSEcCtD
Linezolid—Decreased appetite—Thalidomide—leprosy	0.00493	0.00493	CcSEcCtD
Linezolid—Gastrointestinal disorder—Thalidomide—leprosy	0.00489	0.00489	CcSEcCtD
Linezolid—Fatigue—Thalidomide—leprosy	0.00489	0.00489	CcSEcCtD
Linezolid—Pain—Thalidomide—leprosy	0.00485	0.00485	CcSEcCtD
Linezolid—Constipation—Thalidomide—leprosy	0.00485	0.00485	CcSEcCtD
Linezolid—Gastrointestinal pain—Thalidomide—leprosy	0.00464	0.00464	CcSEcCtD
Linezolid—Urticaria—Thalidomide—leprosy	0.0045	0.0045	CcSEcCtD
Linezolid—Abdominal pain—Thalidomide—leprosy	0.00448	0.00448	CcSEcCtD
Linezolid—Body temperature increased—Thalidomide—leprosy	0.00448	0.00448	CcSEcCtD
Linezolid—Asthenia—Thalidomide—leprosy	0.00407	0.00407	CcSEcCtD
Linezolid—Pruritus—Thalidomide—leprosy	0.00401	0.00401	CcSEcCtD
Linezolid—Diarrhoea—Thalidomide—leprosy	0.00388	0.00388	CcSEcCtD
Linezolid—Dizziness—Thalidomide—leprosy	0.00375	0.00375	CcSEcCtD
Linezolid—Vomiting—Thalidomide—leprosy	0.0036	0.0036	CcSEcCtD
Linezolid—Rash—Thalidomide—leprosy	0.00357	0.00357	CcSEcCtD
Linezolid—Dermatitis—Thalidomide—leprosy	0.00357	0.00357	CcSEcCtD
Linezolid—Headache—Thalidomide—leprosy	0.00355	0.00355	CcSEcCtD
Linezolid—Nausea—Thalidomide—leprosy	0.00337	0.00337	CcSEcCtD
